Skip to main content
Equibles

Woodline Partners LP

Position in LRMR — Larimar Therapeutics, Inc.

CIK 1784547 San Francisco, CA
Back to LRMR Full portfolio

Position in LRMR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,272,592
-$2,031,233 QoQ
Shares Held
1,400,850
0.0% QoQ
Ownership
1.35%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#17
of 163 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LRMR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. LRMR ranks #142 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 2,002,863 $375,096,182
2 PTGX
Protagonist Therapeutics, Inc
 1,414,173 $173,349,326
3 TNGX
Tango Therapeutics, Inc.
 4,000,567 $125,057,724
4 BHVN
Biohaven Ltd.
 7,660,280 $113,984,966
5 COGT
Cogent Biosciences, Inc.
 2,603,162 $100,742,369
6 CYTK
Cytokinetics Inc
 1,100,708 $93,769,314
7 RCUS
Arcus Biosciences, Inc.
 3,007,798 $92,730,412
8 ROIV
Roivant Sciences Ltd.
 2,500,673 $88,498,817

All Filings in LRMR

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,272,592 1,400,850
2026-03-31 $6,303,825 1,400,850
2025-12-31 $3,051,238 800,850
2025-09-30 $5,241,805 1,622,850
2025-06-30 $1,799,550 622,682
2025-03-31 $1,338,766 622,682
2024-12-31 $2,409,779 622,682
2024-09-30 $8,151,809 1,244,551
2024-06-30 $9,008,741 1,242,585
2024-03-31 $8,731,027 1,150,333
2023-12-31 $3,622,828 796,226
2023-09-30 $2,803,239 709,681
2023-06-30 $5,264,387 1,681,913
2023-03-31 $7,619,065 1,681,913
2022-12-31 $8,019,382 1,941,739
2022-09-30 $6,213,564 1,941,739